Coca-Cola enters fray to buy GSK’s consumer nutrition business

GlaxoSmithKline (GSK), a British pharmaceutical giant, put its malted milk drink brand ‘Horlicks’ under a strategic review. According to various sources, there were consumer food giants such as Nestle, HUL and Danone competing for GSK’s consumer nutrition business. Recently, Coca-Cola too has joined the $4-billion-plus pursuit.

Coca-Cola is trying to diversify from its core of aerated drinks to other products. The other product focuses on healthy product such as juices and flavoured water as they want to enter the health market. GlaxoSmithKline Consumer Healthcare in India sells both Horlicks and Boost. According to media reports, the strategic review will include an assessment of GSK’s 72.5% shareholding in the company.

 

Marketing
@adgully

News in the domain of Advertising, Marketing, Media and Business of Entertainment

More in Marketing